Zyprexa, atypical antipsychotic medication with proven safety and efficacy

Published: 2004-09-10 06:58:00

Updated: 2004-09-10 06:58:00

The Korean College of Neuropsychopharmacology said it held on September 3 its autumn symposium for Zyprexa (olanzapine), a psychotropic medication indicated for the treatment of acute manic episodes associated with bipolar I disorder, which was sponsored by Lilly Korea in commemoration of Zyprexa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK